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Abstract
The low incidence of cardiovascular diseases, including hypertension, in premenopausal women has led to the conclusion that 
ovarian hormones may have a protective effect on the cardiovascular system. We evaluated the effects of ovariectomy and/
or estradiol on sympathovagal balance and heart rate variability (HRV) in female spontaneously hypertensive rats (SHR) with 
tachycardia and compared them to Wistar rats (12 weeks old; N = 8-12). Ovariectomy (OVX) and/or estradiol (10 µg/kg) did not 
affect basal arterial pressure in either rat strain, but estradiol increased basal heart rate (HR) in OVX SHR (454 ± 18 vs 377 ± 9 
bpm). HR changes elicited by methylatropine and propranolol were used to evaluate the sympathovagal balance. Ovariectomy 
did not affect the cardiac sympathovagal balance of any group, while estradiol increased sympathetic tone in OVX SHR (120 ± 
8 vs 56 ± 10 bpm) and sham-operated Wistar rats (57 ± 7 vs 28 ± 4 bpm), and decreased the parasympathetic tone only in OVX 
SHR (26 ± 7 vs 37 ± 5 bpm). HRV was studied in the frequency domain (Fast Fourier Transformation). Spectra of HR series 
were examined at low frequency (LF: 0.2-0.75 Hz) and high frequency (HF: 0.75-3 Hz) bands. The power of LF, as well as the 
LF/HF ratio, was not affected by ovariectomy, but estradiol increased both LF (29 ± 4 vs 18 ± 3 nu in Wistar sham-operated, 
26 ± 5 vs 15 ± 3 nu in Wistar OVX, 50 ± 3 vs 38 ± 4 nu in SHR sham-operated, and 51 ± 3 vs 42 ± 3 nu in SHR OVX) and LF/
HF (0.48 ± 0.08 vs 0.23 ± 0.03 nu in Wistar sham-operated, 0.41 ± 0.14 vs 0.19 ± 0.05 nu in Wistar OVX, 0.98 ± 0.11 vs 0.63 
± 0.11 nu in SHR sham-operated, and 1.10 ± 0.11 vs 0.78 ± 0.1 nu in SHR OVX). Thus, we suggest that ovariectomy did not 
affect the cardiac sympathovagal balance of SHR or Wistar rats, while estradiol increased the sympathetic modulation of HR.
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Epidemiological studies indicate a low incidence of 
cardiovascular diseases, including hypertension, in pre-
menopausal women compared to age-matched men (1). 
However, after the onset of menopause, when cardiovas-
cular disorders become a prominent cause of death, this 
difference is no longer demonstrable (2). These data strongly 
suggest that ovarian hormones play a protective role in the 
cardiovascular system of young women (1). However, the 
mechanisms of this protective effect are unknown. Clini-
cal and experimental investigations have suggested the 
existence of gender-related differences in the autonomic 
control of the cardiovascular system (3). There is evidence 
that women exhibit greater parasympathetic control of car-
diovascular function compared to men (4). However, the 
relationship between estrogen levels and the autonomic 
control of the cardiovascular system is also unknown and 
deserves further study.
The increased incidence of cardiovascular risk in post-
menopausal women may also involve changes in arterial 
blood pressure (BP) and its regulation, which is associated 
with estrogen loss. For instance, the incidence of arterial 
hypertension rises markedly following menopause (5). 
Furthermore, since arterial hypertension is a ubiquitous 
cardiovascular disorder and is relatively common among 
women during the menopausal period (5), it has been ac-
cepted that the postmenopausal reduction of estrogen levels 
is quite disturbing to the cardiovascular system. However, 
little is known about the direct effects of low estrogen levels 
on arterial hypertension and its autonomic regulation.
The spontaneously hypertensive rat (SHR) has been an 
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important model for studying the effects of estrogen during 
the development of arterial hypertension (6,7). There are 
a number of studies showing that female SHR have lower 
arterial pressure than male SHR, indicating the influence 
of gender on the development of hypertension (6,8). More-
over, aged female SHR have been accepted as a suitable 
model of postmenopausal hypertension for two reasons: 
1) following the cessation of cycling at approximately 11 
months of age, these animals, like postmenopausal women, 
exhibit low estrogen levels; 2) these animals exhibit higher 
arterial pressure levels compared to young female SHR (6). 
The literature indicates that SHR have greater sympathetic 
tone under basal conditions compared to Wistar rats (9). 
Sympathetic attenuation following estrogen administration 
has also been demonstrated in normotensive male and 
female rats (10).
Heart rate variability (HRV) has been widely used to 
evaluate the autonomic modulation of the cardiovascular 
system in both humans (11) and experimental animals 
(12). HRV can be examined in the time domain (overall 
variability), as well as in the frequency domain (spectral 
analysis). Heart rate (HR) oscillations at low frequency 
(LF: 0.2 to 0.75 Hz) are accepted as an index of cardiac 
sympathetic modulation, while high frequency (HF: 0.75 
to 3 Hz) oscillations of HR are considered to reflect para-
sympathetic modulation of the heart (11). The ratio of LF to 
HF power has been used to evaluate the sympathovagal 
balance (11). Another method used to assess this balance 
is a double-pharmacological blockade of sympathetic and 
parasympathetic receptors in the sinus node (i.e., by means 
of atropine and propranolol) (13).
The influence of estradiol on the cardiovascular system 
has been investigated in a number of clinical and experi-
mental studies and conflicting results have been observed 
(14,15). Moreover, there are few studies regarding the ef-
fects of estradiol on the sympathovagal balance and HRV 
of hypertensive animals, particularly SHR.
Therefore, the present study was undertaken to deter-
mine the effects of ovariectomy, as well as the effects of 
estradiol replacement therapy, on BP levels, cardiac sym-
pathovagal balance, and HRV of conscious female SHR.
Material and Methods
Experiments were performed on 12-week-old female 
SHR and female Wistar rats supplied by the Animal Facility of 
the Faculdade de Medicina de Ribeirão Preto, Universidade 
de São Paulo, São Paulo, SP, Brazil. Rats were housed in 
a temperature-controlled room (21 ± 1°C) with a 12-h light/
dark cycle with free access to water and standard chow 
(Nuvilab CR-1, Nuvital, Brazil). All experimental procedures 
were carried out according to the Guide for the Care and 
Use of Laboratory Animals (DHEW Publication No. (NIH) 
85-23, Revised 1985; Office of Science and Health Reports, 
DRR/NIH, Bethesda, MD, USA) and were approved by the 
Ethics Committee for Animal Research of the Faculdade de 
Medicina de Ribeirão Preto, Universidade de São Paulo, 
Ribeirão Preto, SP, Brazil (Protocol #0076/2006).
Ovariectomy and estradiol therapy
The animals were anesthetized with tribromoethanol 
(250 mg/kg, ip, Sigma, USA) and submitted to bilateral 
ovariectomy (OVX) or sham removal of the ovaries. All 
animals received prophylactic antibiotic therapy following 
the surgical procedures. Animals were allowed one week to 
recover from the surgical procedures when subcutaneous 
injections of estradiol benzoate (10 µg/kg; Sigma) or corn 
oil (vehicle) were applied daily for 21 days.
Before the experiments, all rats underwent estrous cycle 
evaluation (vaginal smear) and only rats presenting at least 
three regular cycles were included in the study. Next, the 
estrous cycle phase was evaluated every day during the 
last 15 days of therapy (estradiol or vehicle) to confirm that 
intact rats treated with vehicle were cycling regularly, OVX 
treated with vehicle remained in diestrus, while estradiol-
treated rats (sham-operated or OVX) remained in constant 
proestrus.
Experimental groups
SHR were assigned to the following four groups: sham-
operated rats treated with vehicle (N = 12), sham-operated 
rats treated with estradiol (N = 8), OVX rats treated with 
vehicle (N = 10), and OVX rats treated with estradiol (N 
= 12). Wistar rats were assigned to the following four 
groups: sham-operated rats treated with vehicle (N = 9), 
sham-operated rats treated with estradiol (N = 10), OVX 
rats treated with vehicle (N = 12), and OVX rats treated 
with estradiol (N = 9).
Heart rate and arterial pressure recordings 
After 21 days of estradiol or vehicle treatment, all animals 
were anesthetized with tribromoethanol (250 mg/kg, ip) and 
implanted with subcutaneous electrocardiogram (ECG) 
electrodes (lead I) and a catheter (PE-10; Clay Adams, 
USA) into the femoral vein. The animals were then allowed 
to recover for 48 h prior to the experimental protocol, which 
was carried out without anesthesia. The animals were taken 
to the recording room at least 1 h before the beginning of 
the recordings, and a quiet environment was maintained to 
avoid stress. ECG electrodes were connected to a bioelectric 
amplifier (8811A, Hewlett Packard, USA) and the ECG was 
continuously sampled (2 kHz) using an IBM/PC computer 
equipped with an analog-to-digital interface (CAD 12/36, 
Lynx Tecnologia Eletrônica, Brazil). After 30 min of basal 
ECG recording, the rats received methylatropine (2 mg/kg, 
iv, Sigma) followed by propranolol (4 mg/kg, iv, Sigma) 15 
min later to permit the measurement of the intrinsic heart 
rate (iHR). The same animals were submitted to another 
recording period 24 h later with the same autonomic blockers 
(i.e., methylatropine and propranolol) given in the opposite 
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order. The sympathetic tone was considered to be the HR 
response to propranolol in rats subjected to the methylatro-
pine/propranolol sequence, while the parasympathetic tone 
was the HR response to methylatropine in rats subjected to 
the propranolol/methylatropine sequence. Therefore, both 
basal HR and iHR were measured twice for each rat. The 
averages of the two data sets of these parameters were 
calculated for each animal.
Following the second ECG recording, the rats had a 
catheter implanted into the femoral artery under tribromo-
ethanol anesthesia. Twenty-four hours after catheterization, 
the arterial line was connected to a pressure transducer 
(Statham, P10E2, USA) and pulsatile arterial pressure was 
sampled (2 kHz) for 30 min using an IBM/PC equipped with 
an analog-to-digital interface.
Heart rate variability
The spectral density of the various frequency compo-
nents of HR was calculated using Fast Fourier Transforma-
tion (FFT). This analysis requires data collection at equal 
time intervals. Therefore, beat-by-beat HR data obtained 
from the first 15 min of the first recording period were con-
verted to data points every 100 ms using a cubic spline 
interpolation (10 Hz). The interpolated series was divided 
into half-overlapping sequential sets of 512 data points 
(51.2 s). Before calculation of the spectral power density, 
the segments were inspected visually and nonstationary 
data were not taken into consideration. A Hanning window 
was used to attenuate side effects and the spectrum was 
computed using a direct FFT algorithm for discrete time 
series. The spectra were integrated in the 
LF band (0.2-0.75 Hz) and HF band (0.75-3 
Hz), and spectral components are presented 
in a normalized form by dividing them by the 
total power minus the DC component (16), 
since the very low frequency (VLF) band 
was removed. The LF/HF ratio is also shown, 
defined by the LF power divided by the HF 
power, characterizing the sympathovagal 
balance (11,16).
Statistical analysis 
The effects of factor such as strain (Wistar 
rats or SHR), surgery (ovariectomy or sham 
operation) and treatment (estradiol or vehicle) 
on basal HR, arterial pressure, vagal and 
sympathetic tone, iHR, as well as the HRV 
data were tested by three-way analysis of 
variance. When the effect on any factor, as 
well as the interactions among them, was 
found to be significant all pairwise multiple 
comparisons were performed by the Student-
Newman-Keuls post hoc test. Differences 
were considered to be statistically significant 
if P < 0.05.
Results
Basal arterial pressure
Basal levels of systolic, diastolic and mean BP are 
shown in Table 1. As expected, BP was higher in SHR than 
in Wistar rats, while ovariectomy and/or estradiol did not 
affect these basal levels.
Autonomic control of heart rate
Figure 1 shows basal HR (dotted horizontal lines), HR 
after the administration of each autonomic receptor blocker, 
as well as the iHR (solid horizontal lines) of all groups of rats 
studied, i.e., SHR (right panel) and Wistar rats (left panel) 
submitted to ovariectomy or sham-operation, treated with 
estradiol or vehicle. As shown in Figure 1, SHR exhibited 
greater basal HR, greater cardiac sympathetic tone, as 
well as smaller cardiac vagal tone compared to Wistar 
rats. Basal HR, cardiac sympathetic tone, as well as iHR 
were found to be similar in OVX and sham-operated rats. 
Nevertheless, the significant surgery x strain interaction 
for these variables can be interpreted as an indication that 
ovariectomy did exert an effect on basal HR and on the 
HR response to atropine in a rat strain-dependent manner. 
However, treatment with estradiol increased both basal HR 
and sympathetic tone, while it decreased cardiac vagal 
tone in OVX SHR. In contrast, estradiol did not affect these 
parameters in sham-operated SHR. Figure 1 also shows 
that estradiol increased sympathetic tone in sham-operated, 
but not in OVX Wistar rats.
Finally, the iHR was not affected by ovariectomy and/
Table 1. Effect of estradiol on systolic (SAP), mean (MAP) and diastolic (DAP) 
arterial pressures (mmHg) of sham-operated and ovariectomized female spon-
taneously hypertensive rats (SHR) and Wistar rats.
Sham-operated Ovariectomized
Vehicle Estradiol Vehicle Estradiol
Spontaneously hypertensive rat
SAP 183 ± 6 183 ± 6 173 ± 5 164 ± 5
MAP 151 ± 6 155 ± 5 145 ± 5 139 ± 4
DAP 121 ± 7 129 ± 5 117 ± 5 115 ± 4
Wistar rat
SAP 122 ± 5* 120 ± 2* 118 ± 2* 123 ± 5*
DAP 99 ± 4*  95 ± 2*  97 ± 2* 99 ± 5*
MAP 83 ± 4*  79 ± 1*  81 ± 2* 82 ± 4*
Data are reported as means ± SEM. Three-way ANOVA showed a strain effect 
(Wistar vs SHR) for basal systolic, mean and diastolic arterial blood pressures 
(P < 0.001). No significant effects of surgery (sham operation vs ovariectomy) or 
treatment (vehicle vs estrogen) on arterial pressure were detected. Interactions 
between strain and treatment and between surgery and treatment were also 
not statistically significant. *P < 0.05 compared to SHR (Student-Newman-Keuls 
post-test).
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or estradiol in any group of rats examined.
Heart rate variability
Figure 2 shows that pulse interval (PI) spectra from 
Wistar rats presented a lower power of the LF band and 
a higher power of the HF band, as well as a lower LF/HF 
ratio, compared to SHR. Ovariectomy did not affect LF or 
HF power, while estradiol increased LF and decreased HF 
power of PI spectra in both rat strains. Finally, ovariectomy 
did not affect the LF/HF ratio, while estradiol did. When HRV 
was examined in the time domain, ovariectomy did not affect 
the cardiac PI in either rat strain. Nevertheless, estradiol 
did affect the PI only in SHR submitted to ovariectomy. No 
effect of ovariectomy and/or estradiol was observed on PI 
variance in either rat strain.
Discussion
Despite the evidence from the literature that the lack of 
estrogen can contribute to sympathoexcitation, as well as 
increasing arterial pressure, our results did not show any 
conspicuous effect of ovariectomy on basal BP and HR 
levels of female SHR or Wistar rats. Moreover, estrogen 
treatment not only failed to decrease the sympathetic tone, 
but rather increased it.
The estrogen levels achieved with chronic estradiol 
therapy were not measured in the present study. Although 
it is recognized that different regimens of estradiol ad-
ministration may produce different hormone level profiles 
(17), a therapy similar to that used in the present study led 
to estradiol levels comparable to those observed during 
proestrous (18).
As reported in previous studies, ovariectomy promotes 
a marked reduction of estrogen levels (19). Nevertheless, 
in our study, ovariectomy did not affect cardiac autonomic 
tone. One may hypothesize that, after removing the ova-
ries, a number of other forms of estrogen may have been 
increased by peripheral hormone synthesis (19), explain-
ing why ovariectomy failed to demonstrate any effect on 
autonomic tone. In the present study, ovariectomy was 
performed in young adult female rats, a different model 
from menopausal estrogen depletion (20).
Basal arterial pressure
The hypertensive levels exhibited by female SHR 
compared to female Wistar rats agreed with previous data 
from the literature (21) obtained in the same time frame as 
examined in the present study. In the current study, ova-
riectomy and/or estradiol did not affect basal BP of female 
SHR or Wistar rats. There is no consensus in the literature 
regarding the effects of ovariectomy and/or estradiol therapy 
on BP levels.
Previous studies have indicated that ovariectomy did 
not affect BP of conscious (22) or anesthetized (23), hyper-
Figure 1. Effect of estradiol on cardiac sympathetic and vagal tones. Bar graphs showing basal heart rate (dotted horizontal line), intrinsic 
heart rate (solid horizontal line) and heart rate responses to propranolol after methyl-atropine (cardiac sympathetic tone: gray bars) or to 
methyl-atropine after propranolol (cardiac vagal tone: open bars) of sham-operated and ovariectomized (OVX) spontaneously hyperten-
sive rats (SHR) and Wistar rats treated with vehicle or estradiol. Three-way ANOVA showed a strain effect (Wistar vs SHR) for basal HR 
(P < 0.001) and for HR response to propranolol (P = 0.003) and methyl-atropine (P < 0.001). No significant effect of surgery (sham opera-
tion vs ovariectomy) was detected on any parameter shown in the figure. Treatment effect (vehicle vs estrogen) was significant for basal 
HR (P = 0.003) and for HR response to methylatropine (P < 0.001). Interaction between strain and surgery was significant for basal HR 
(P = 0.047) and for HR response to methylatropine (P = 0.013). Interaction between strain and treatment was significant only for basal HR 
(P = 0.005). No differences were found for interaction between surgery and treatment for the parameters shown in the figure. *P < 0.05 
compared to the same parameter of OVX SHR treated with vehicle; †P < 0.05 compared to the same parameter of sham-operated Wistar 
treated with vehicle; ‡P < 0.05 compared to the same parameter of SHR (Student-Newman-Keuls post hoc test).
Estradiol increases sympathovagal balance of female SHR 973
www.bjournal.com.br Braz J Med Biol Res 43(10) 2010
tensive or normotensive female rats. There are, however, 
studies showing that hypertensive and normotensive rats 
submitted to ovariectomy exhibited an increase in BP (24), 
which was reversed (24), or not (22), by chronic estradiol 
therapy. It is likely that this lack of consensus is due to 
either the different methods used for BP recording or to a 
modulatory role of estrogen on the central nervous system 
(CNS) and/or peripheral organs, whose effect is not yet well 
understood. Nevertheless, the results of the current study 
indicate, by means of direct recording of the BP without 
the undesirable effect of anesthesia, that ovariectomy 
and/or estradiol did not affect the BP of female SHR or 
Wistar rats.
Autonomic control of heart rate
Ovariectomy did not affect basal HR, sympathovagal 
balance, or iHR in female SHR and Wistar rats. However, 
female sham-operated Wistar rats showed greater cardiac 
sympathetic tone following chronic estradiol administration. 
This therapy also affected the female SHR submitted to 
ovariectomy, increasing basal HR and sympathetic tone 
and decreasing parasympathetic tone. Thus, the results 
of the present study demonstrate that estrogen therapy 
causes an imbalance in the autonomic control of HR, 
displacing the equilibrium toward increased sympathetic 
activity. Since iHR did not differ among groups, this finding 
indicates that ovariectomy and/or estradiol most likely did 
not act directly on the sinus node. It is likely that estradiol 
affects the sympathetic tone by means of an action on the 
CNS, since there are estrogen receptors in areas of the 
CNS related to cardiovascular control, such as preoptic 
area, paraventricular nucleus and nucleus of the tractus 
solitarii (25,26).
There is, however, evidence that estradiol administra-
tion directly into nuclei related to cardiovascular control 
decreases sympathetic and increases parasympathetic 
activity in male Sprague Dawley rats (27). Experiments 
carried out in vitro have shown that supra-physiological es-
trogen levels decrease tyrosine hydroxylase (a rate-limiting 
enzyme in catecholamine biosynthesis) production (28), 
while ovariectomy reduces acetylcholine synthesis in the 
CNS, which is restored by chronic estrogen therapy (29).
Heart rate variability
HRV is used as an important index of cardiac autonomic 
modulation and is usually taken as a parameter of cardio-
vascular health (11,16). Analysis of HRV in the frequency 
domain (spectral analysis) allows the evaluation of cardiac 
autonomic modulation. The power of the LF band of HR 
spectra is widely accepted as an index of sympathetic 
modulation, while the power of the HF band is associated 
with parasympathetic modulation (11). Nevertheless, there 
is evidence that the LF power of HR spectra also represents 
parasympathetic modulation (30). Thus, the power of LF 
and HF bands represent more accurately the autonomic 
modulation when presented in normalized units, or by 
means of the LF/HF ratio (16). The results of the present 
study showed that ovariectomy did not affect HR spectra 
or the LF/HF ratio of the HR spectra of female SHR and 
Wistar rats. However, the power of LF was increased while 
the power of HF was decreased under estradiol, leading to 
an increased LF/HF ratio in both rat strains studied. These 
data suggest that estradiol treatment elicited autonomic 
imbalance, with sympathetic predominance, in female rats 
Figure 2. Upper panel, Power of HR spectra at the low frequency 
(LF) band (normalized units; nu) for sham-operated and ova-
riectomized (OVX) spontaneously hypertensive rats (SHR) and 
Wistar rats treated with vehicle or estradiol. Middle panel, Power 
of HR spectra at the high frequency (HF) band from sham-oper-
ated and OVX SHR and Wistar rats treated with vehicle or estra-
diol. Lower panel, Ratio between the power of HR spectra at the 
LF and HF bands for sham-operated and OVX female SHR and 
Wistar rats treated with vehicle or estradiol. Three-way ANOVA 
showed a significant effect of both strain (Wistar vs SHR) and 
treatment (vehicle vs estrogen) for LF, HF and LF/HF (P < 0.001). 
No significant effect of surgery (sham operation or ovariectomy) 
was detected on any parameter shown in the figure. Interactions 
between strain and surgery, strain and treatment or surgery and 
treatment were not significant. *P < 0.05 compared to vehicle; 
†P < 0.05 compared to SHR (Student-Newman-Keuls post hoc 
test).
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of both strains, suggesting that the preexisting autonomic 
imbalance of SHR did not play a major role in the effect of 
estrogen treatment in the animals studied.
A number of studies have indicated that acute systemic 
administration of estrogen decreases sympathetic and 
increases parasympathetic activity in female and male 
Sprague Dawley rats (10,31). Moreover, the sympathetic 
overactivity observed following middle cerebral artery oc-
clusion is attenuated by previous estrogen injection into the 
parabrachial nucleus of male Sprague Dawley rats (32). In 
addition, when an estrogen antagonist is previously injected 
into the nucleus tractus solitarii of male Sprague Dawley 
rats, the estrogen-mediated recovery of autonomic function 
following middle cerebral artery occlusion is attenuated, 
supporting the importance of estrogen receptor availability 
within the CNS (27).
Nevertheless, a careful examination of the literature 
revealed conflicting results regarding the effects of estradiol 
therapy on the autonomic tone of women. In agreement 
with our findings is the observation that during a regular 
menstrual cycle when estradiol concentration is high, there 
is an increase in sympathetic activity with no change in 
arterial pressure (33). Moreover, direct recordings from 
peripheral sympathetic nerves revealed increased sympa-
thetic outflow during pregnancy in women (34) as well as 
an increase in tyrosine hydroxylase in adrenal glands and 
superior cervical ganglia during pregnancy as compared 
to diestrus and ovariectomy (35).
A hypothesis to explain the high sympathetic activity 
following estradiol therapy could take into account the effect 
of this hormone on nitric oxide (NO), since NO production 
is increased by estrogen (36). Thus, the increase in sym-
pathetic activity might be explained as a compensatory 
mechanism for the reduced vascular tone elicited by NO, 
such as the sympathetic activation elicited by the fall in 
pressure due to nifedipine treatment in hypertensive pa-
tients (37). Nevertheless, the mechanisms responsible for 
the sympatho-excitation found in rats treated with estrogen 
remains to be elucidated.
The findings of the present study indicate that ovariec-
tomy did not affect the cardiac sympathovagal balance 
in either rat strain, while estradiol increased the cardiac 
sympathovagal balance of female SHR and Wistar rats. 
Despite the evidence that hormone replacement therapy 
may positively affect the cardiovascular system reducing the 
risk of cardiovascular disturbances (38,39), the results of 
the present study agree with clinical evidence (40) indicat-
ing that estradiol therapy may not affect, or may negatively 
affect, the cardiovascular system, since after estrogen 
therapy the cardiovascular risk may not be reduced and 
the probability of cardiovascular derangements may be 
increased in women.
Acknowledgments
Research supported by FAPESP, CAPES and CNPq.
 1. Becker RC, Corrao JM. Cardiovascular disease in women: 
scope of the problem. Cardiology 1990; 77 (Suppl 2): 6-7.
 2. Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natu-
ral menopause and cause-specific mortality. Am J Epidemiol 
2005; 162: 1089-1097.
 3. Dart AM, Du XJ, Kingwell BA. Gender, sex hormones and 
autonomic nervous control of the cardiovascular system. 
Cardiovasc Res 2002; 53: 678-687.
 4. Ryan SM, Goldberger AL, Pincus SM, Mietus J, Lipsitz LA. 
Gender- and age-related differences in heart rate dynam-
ics: are women more complex than men? J Am Coll Cardiol 
1994; 24: 1700-1707.
 5. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones 
and hypertension. Cardiovasc Res 2002; 53: 688-708.
 6. Fortepiani LA, Zhang H, Racusen L, Roberts LJ, Reckelhoff 
JF. Characterization of an animal model of postmenopausal 
hypertension in spontaneously hypertensive rats. Hyperten-
sion 2003; 41: 640-645.
 7. van Eickels M, Schreckenberg R, Doevendans PA, Meyer R, 
Grohe C, Schluter KD. The influence of oestrogen-deficiency 
and ACE inhibition on the progression of myocardial hyper-
trophy in spontaneously hypertensive rats. Eur J Heart Fail 
2005; 7: 1079-1084.
 8. Reckelhoff JF, Zhang H, Granger JP. Testosterone exac-
erbates hypertension and reduces pressure-natriuresis in 
male spontaneously hypertensive rats. Hypertension 1998; 
31: 435-439.
 9. Lundin S, Ricksten SE, Thoren P. Renal sympathetic activ-
ity in spontaneously hypertensive rats and normotensive 
controls, as studied by three different methods. Acta Physiol 
Scand 1984; 120: 265-272.
10. Saleh TM, Connell BJ, Saleh MC. Acute injection of 17beta-
estradiol enhances cardiovascular reflexes and autonomic 
tone in ovariectomized female rats. Auton Neurosci 2000; 
84: 78-88.
11. Heart rate variability. Standards of measurement, physi-
ological interpretation, and clinical use. Task Force of the 
European Society of Cardiology and the North American 
Society of Pacing and Electrophysiology. Eur Heart J 1996; 
17: 354-381.
12. Fazan R Jr, Dias da Silva V, Ballejo G, Salgado HC. Power 
spectra of arterial pressure and heart rate in streptozotocin-
induced diabetes in rats. J Hypertens 1999; 17: 489-495.
13. Jose AD, Taylor RR. Autonomic blockade by propranolol and 
atropine to study intrinsic myocardial function in man. J Clin 
Invest 1969; 48: 2019-2031.
14. Hulley S, Grady D, Bush T, Furberg C, Herrington D, 
Riggs B, et al. Randomized trial of estrogen plus proges-
tin for secondary prevention of coronary heart disease in 
postmenopausal women. Heart and Estrogen/Progestin 
References
Estradiol increases sympathovagal balance of female SHR 975
www.bjournal.com.br Braz J Med Biol Res 43(10) 2010
Replacement Study (HERS) Research Group. JAMA 1998; 
280: 605-613.
15. Vongpatanasin W, Tuncel M, Mansour Y, Arbique D, Victor 
RG. Transdermal estrogen replacement therapy decreases 
sympathetic activity in postmenopausal women. Circulation 
2001; 103: 2903-2908.
16. Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, 
Malliani A. Power spectrum analysis of heart rate variability 
to assess the changes in sympathovagal balance during 
graded orthostatic tilt. Circulation 1994; 90: 1826-1831.
17. Strom JO, Theodorsson E, Holm L, Theodorsson A. Differ-
ent methods for administering 17beta-estradiol to ovariec-
tomized rats result in opposite effects on ischemic brain 
damage. BMC Neurosci 2010; 11: 39.
18. Yang X, Liu R, Dong Y. Regulative effects of ovarian steroids 
on rat gastric motility and sensitivity. Sheng Li Xue Bao 2006; 
58: 275-280.
19. Davidge ST, Zhang Y, Stewart KG. A comparison of ovariec-
tomy models for estrogen studies. Am J Physiol Regul Integr 
Comp Physiol 2001; 280: R904-R907.
20. Clark JT, Chakraborty-Chatterjee M, Hamblin M, Wyss JM, 
Fentie IH. Estrogen depletion differentially affects blood 
pressure depending on age in Long-Evans rats. Endocrine 
2004; 25: 173-186.
21. Kauser K, Rubanyi GM. Gender difference in endothelial 
dysfunction in the aorta of spontaneously hypertensive rats. 
Hypertension 1995; 25: 517-523.
22. Gimenez J, Garcia MP, Serna M, Bonacasa B, Carbonell 
LF, Quesada T, et al. 17Beta-oestradiol enhances the acute 
hypotensive effect of captopril in female ovariectomized 
spontaneously hypertensive rats. Exp Physiol 2006; 91: 
715-722.
23. Jazbutyte V, Hu K, Kruchten P, Bey E, Maier SK, Fritzemeier 
KH, et al. Aging reduces the efficacy of estrogen substitution 
to attenuate cardiac hypertrophy in female spontaneously 
hypertensive rats. Hypertension 2006; 48: 579-586.
24. Dantas AP, Scivoletto R, Fortes ZB, Nigro D, Carvalho MH. 
Influence of female sex hormones on endothelium-derived 
vasoconstrictor prostanoid generation in microvessels of 
spontaneously hypertensive rats. Hypertension 1999; 34: 
914-919.
25. Pelletier G, Liao N, Follea N, Govindan MV. Mapping of 
estrogen receptor-producing cells in the rat brain by in situ 
hybridization. Neurosci Lett 1988; 94: 23-28.
26. Stefano GB, Prevot V, Beauvillain JC, Cadet P, Fimiani C, 
Welters I, et al. Cell-surface estrogen receptors mediate 
calcium-dependent nitric oxide release in human endothelia. 
Circulation 2000; 101: 1594-1597.
27. Saleh TM, Cribb AE, Connell BJ. Role of estrogen in central 
nuclei mediating stroke-induced changes in autonomic tone. 
J Stroke Cerebrovasc Dis 2003; 12: 182-195.
28. Lloyd T, Weisz J. Direct inhibition of tyrosine hydroxylase 
activity by catechol estrogens. J Biol Chem 1978; 253: 4841-
4843.
29. O’Malley CA, Hautamaki RD, Kelley M, Meyer EM. Effects of 
ovariectomy and estradiol benzoate on high affinity choline 
uptake, ACh synthesis, and release from rat cerebral cortical 
synaptosomes. Brain Res 1987; 403: 389-392.
30. Appel ML, Berger RD, Saul JP, Smith JM, Cohen RJ. Beat to 
beat variability in cardiovascular variables: noise or music? 
J Am Coll Cardiol 1989; 14: 1139-1148.
31. Saleh TM, Connell BJ. Centrally mediated effect of 17beta-
estradiol on parasympathetic tone in male rats. Am J Physiol 
1999; 276: R474-R481.
32. Saleh TM, Connell BJ, Cribb AE. Estrogen in the parabra-
chial nucleus attenuates the sympathoexcitation following 
MCAO in male rats. Brain Res 2005; 1066: 187-195.
33. Minson CT, Halliwill JR, Young TM, Joyner MJ. Influence of 
the menstrual cycle on sympathetic activity, baroreflex sensi-
tivity, and vascular transduction in young women. Circulation 
2000; 101: 862-868.
34. Greenwood JP, Scott EM, Stoker JB, Walker JJ, Mary DA. 
Sympathetic neural mechanisms in normal and hypertensive 
pregnancy in humans. Circulation 2001; 104: 2200-2204.
35. Anglin JC, Brooks VL. Tyrosine hydroxylase and norepi-
nephrine transporter in sympathetic ganglia of female rats 
vary with reproductive state. Auton Neurosci 2003; 105: 
8-15.
36. Rahimian R, Chan L, Goel A, Poburko D, van Breemen C. 
Estrogen modulation of endothelium-derived relaxing factors 
by human endothelial cells. Biochem Biophys Res Commun 
2004; 322: 373-379.
37. Leppert J, Nilsson H, Myrdal U, Edvinsson L, Hedner T, 
Ringqvist I. Sympathetic activation after two weeks of nife-
dipine treatment in primary Raynaud’s patients and controls. 
Cardiovasc Drugs Ther 1993; 7: 901-907.
38. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson 
JE, Joffe M, et al. Postmenopausal hormone therapy and 
mortality. N Engl J Med 1997; 336: 1769-1775.
39. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett 
WC, Rosner B, et al. Postmenopausal estrogen and proges-
tin use and the risk of cardiovascular disease. N Engl J Med 
1996; 335: 453-461.
40. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Koop-
erberg C, Stefanick ML, et al. Risks and benefits of estrogen 
plus progestin in healthy postmenopausal women: principal 
results From the Women’s Health Initiative randomized 
controlled trial. JAMA 2002; 288: 321-333.
